Science Writing Competition: Rolling back malaria

  1. Philippa C Matthews  Is a corresponding author
  1. University of Oxford, United Kingdom

Abstract

Efforts to fight malaria in Africa are proving successful in many countries, but a population explosion means that there is still a long way to go.

Main text

This article by Philippa C Matthews (pictured) was the winning entry in the 2015 Access to Understanding science-writing competition organized by the British Library in partnership with eLife and Europe PMC. Access to Understanding promotes understanding of biomedical research. Competition entrants were challenged to summarize selected scientific research articles in plain English, explaining why the research was done, what was done and why it is important.

Plasmodium falciparum is the most deadly of all malaria parasites. Children are particularly vulnerable to the devastating consequences of this infection, and the World Health Organisation (WHO) estimates that a child in Africa dies from malaria every minute (WHO, 2014). In recognition of this crisis, malaria has become a headline priority in global health, with campaigns such as the Roll Back Malaria initiative spearheading a huge international effort to tackle the disease.

Abdisalan Noor and colleagues set out to assess how much progress has been made across Africa in the Roll Back Malaria era. Have the immense resources deployed made a real difference to some of the world's most vulnerable populations? How has the burden of malaria altered in the decade since 2000? And can we identify whether infection risks have changed by country or region? With these questions in mind, Noor and colleagues developed a method to measure the changing patterns of malaria risk in Africa as precisely as possible (Noor et al., 2014).

The symptoms of malaria can mimic those of many other infections, and suspected cases of malaria are often treated in the absence of a definite diagnosis and without attending a hospital or clinic. For these reasons, trying to get a clear picture of the scale of the malaria problem in Africa is a major challenge. Noor and colleagues chose to measure malaria by the most accurate method available, which involved looking for studies that had actually identified P. falciparum parasites in the blood. Their final analysis draws on data collected from 3.5 million individuals from over 26,000 surveys spanning 49 regions of Africa, with each piece of information linked to its precise geographic origin by satellite technology.

The researchers—who are based at the Kenya Medical Research Institute-Wellcome Trust Research Programme in Nairobi, Oxford University and the WHO Regional Office for Africa in the Republic of Congo—fed this vast mine of data into a carefully constructed computational analysis. Each piece of information was adjusted to account for when and where it was collected, and the data were then standardized to work out the rate of infection in the age group of interest—the highly vulnerable population of children aged 2–10 years. They also factored in a host of complex influences on malaria transmission, such as urbanisation and climate. The final output was a measure of malaria risk for each individual square kilometre of Africa, first in 2000 and again a decade later. Each of these tiny squares was then classified into one of eight different malaria risk categories.

From this analysis, Noor and colleagues report several substantial and encouraging improvements in the patterns of malaria in Africa. Strikingly, they calculated that 217 million people in Africa were living in a lower risk area in 2010 than they did in 2000. They also found an overall reduction in malaria transmission in 40 of the 44 countries that they assessed in detail. Moreover, four territories—South Africa, Eritrea, Ethiopia and Cape Verde—had successfully reduced malaria into the lowest risk category by 2010. By this time, the majority of the transmission in the highest risk category was occurring in just ten countries.

However, the results also provide a sobering insight into the effects of the population explosion in Africa. This has increased the total numbers of people at risk of malaria; worryingly, over 50% of the population still live in regions of substantial risk. Rates of infection have also remained unchanged or have increased in some countries between 2000 and 2010: Malawi and South Sudan are highlighted as areas for increasing concern, and high transmission has continued across many parts of Nigeria and the Democratic Republic of Congo.

Noor and colleagues also report some areas of difficulty. Despite a data collection effort that spanned eight years, they were still unable to find enough information to assess the malaria risk for certain regions of Africa. Moreover, the vastly complex nature of malaria transmission cannot be completely captured or measured by a computer-based method. Overall, however, the results of this analysis provide valuable feedback for organizations trying to improve population health in many parts of Africa.

As well as amassing a vast amount of information about the distribution of malaria, the researchers also thought hard about the impact of the rapidly changing social and geographical landscape of Africa, ranging from urbanisation to changes in rainfall patterns. The detailed maps they have produced also highlight how the risks of an infection can wax and wane, reminding us of the need to constantly re-assess the best way to keep pace with changing patterns of disease. Noor and colleagues conclude with cautious optimism about the progress made since 2000, but provide a timely warning that the challenge of malaria is far from over.

References

    1. WHO
    (2014) Malaria Fact Sheet: Number 94
    Available at: http://www.who.int/mediacentre/factsheets/fs094/en/.

Article and author information

Author details

  1. Philippa C Matthews

    NIHR Academic Clinical Lecturer in the Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    For correspondence
    p.matthews@doctors.org.uk
    Competing interests
    The author declares that no competing interests exist.

Publication history

  1. Version of Record published: March 30, 2015 (version 1)

Copyright

© 2015, Matthews

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 732
    views
  • 70
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Philippa C Matthews
(2015)
Science Writing Competition: Rolling back malaria
eLife 4:e07364.
https://doi.org/10.7554/eLife.07364

Further reading

    1. Microbiology and Infectious Disease
    Magdalena Podkowik, Andrew I Perault ... Bo Shopsin
    Research Article

    The agr quorum-sensing system links Staphylococcus aureus metabolism to virulence, in part by increasing bacterial survival during exposure to lethal concentrations of H2O2, a crucial host defense against S. aureus. We now report that protection by agr surprisingly extends beyond post-exponential growth to the exit from stationary phase when the agr system is no longer turned on. Thus, agr can be considered a constitutive protective factor. Deletion of agr resulted in decreased ATP levels and growth, despite increased rates of respiration or fermentation at appropriate oxygen tensions, suggesting that Δagr cells undergo a shift towards a hyperactive metabolic state in response to diminished metabolic efficiency. As expected from increased respiratory gene expression, reactive oxygen species (ROS) accumulated more in the agr mutant than in wild-type cells, thereby explaining elevated susceptibility of Δagr strains to lethal H2O2 doses. Increased survival of wild-type agr cells during H2O2 exposure required sodA, which detoxifies superoxide. Additionally, pretreatment of S. aureus with respiration-reducing menadione protected Δagr cells from killing by H2O2. Thus, genetic deletion and pharmacologic experiments indicate that agr helps control endogenous ROS, thereby providing resilience against exogenous ROS. The long-lived ‘memory’ of agr-mediated protection, which is uncoupled from agr activation kinetics, increased hematogenous dissemination to certain tissues during sepsis in ROS-producing, wild-type mice but not ROS-deficient (Cybb−/−) mice. These results demonstrate the importance of protection that anticipates impending ROS-mediated immune attack. The ubiquity of quorum sensing suggests that it protects many bacterial species from oxidative damage.

    1. Medicine
    2. Microbiology and Infectious Disease
    Yi-Shin Chang, Kai Huang ... David L Perkins
    Research Article

    Background:

    End-stage renal disease (ESRD) patients experience immune compromise characterized by complex alterations of both innate and adaptive immunity, and results in higher susceptibility to infection and lower response to vaccination. This immune compromise, coupled with greater risk of exposure to infectious disease at hemodialysis (HD) centers, underscores the need for examination of the immune response to the COVID-19 mRNA-based vaccines.

    Methods:

    The immune response to the COVID-19 BNT162b2 mRNA vaccine was assessed in 20 HD patients and cohort-matched controls. RNA sequencing of peripheral blood mononuclear cells was performed longitudinally before and after each vaccination dose for a total of six time points per subject. Anti-spike antibody levels were quantified prior to the first vaccination dose (V1D0) and 7 d after the second dose (V2D7) using anti-spike IgG titers and antibody neutralization assays. Anti-spike IgG titers were additionally quantified 6 mo after initial vaccination. Clinical history and lab values in HD patients were obtained to identify predictors of vaccination response.

    Results:

    Transcriptomic analyses demonstrated differing time courses of immune responses, with prolonged myeloid cell activity in HD at 1 wk after the first vaccination dose. HD also demonstrated decreased metabolic activity and decreased antigen presentation compared to controls after the second vaccination dose. Anti-spike IgG titers and neutralizing function were substantially elevated in both controls and HD at V2D7, with a small but significant reduction in titers in HD groups (p<0.05). Anti-spike IgG remained elevated above baseline at 6 mo in both subject groups. Anti-spike IgG titers at V2D7 were highly predictive of 6-month titer levels. Transcriptomic biomarkers after the second vaccination dose and clinical biomarkers including ferritin levels were found to be predictive of antibody development.

    Conclusions:

    Overall, we demonstrate differing time courses of immune responses to the BTN162b2 mRNA COVID-19 vaccination in maintenance HD subjects comparable to healthy controls and identify transcriptomic and clinical predictors of anti-spike IgG titers in HD. Analyzing vaccination as an in vivo perturbation, our results warrant further characterization of the immune dysregulation of ESRD.

    Funding:

    F30HD102093, F30HL151182, T32HL144909, R01HL138628. This research has been funded by the University of Illinois at Chicago Center for Clinical and Translational Science (CCTS) award UL1TR002003.